Salarius Pharmaceuticals Files 8-K
Ticker: DCOY · Form: 8-K · Filed: Mar 11, 2025 · CIK: 1615219
Sentiment: neutral
Topics: 8-K, financial-reporting, corporate-events
TL;DR
Salarius Pharma filed an 8-K on March 11th, reporting March 10th events. Financials and exhibits included.
AI Summary
Salarius Pharmaceuticals, Inc. filed an 8-K on March 11, 2025, reporting on events that occurred on March 10, 2025. The filing includes financial statements and exhibits. The company, formerly known as Flex Pharma, Inc., is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This filing provides an update on Salarius Pharmaceuticals' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and exhibits, not indicating any immediate operational or financial distress.
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- Flex Pharma, Inc. (company) — Former company name
- March 10, 2025 (date) — Date of earliest event reported
- March 11, 2025 (date) — Date of report
- Houston, TX (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on "Other Events" and to include "Financial Statements and Exhibits" as of March 10, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 10, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Salarius Pharmaceuticals, Inc.
What was Salarius Pharmaceuticals, Inc. formerly known as?
Salarius Pharmaceuticals, Inc. was formerly known as Flex Pharma, Inc.
Where are Salarius Pharmaceuticals, Inc.'s principal executive offices located?
Salarius Pharmaceuticals, Inc.'s principal executive offices are located at 2450 Holcombe Blvd. Suite X Houston, TX 77021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).